BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 33261212)

  • 1. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
    Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey.
    Fernandes ACF; Melo JB; Genova VM; Santana ÁL; Macedo G
    Recent Adv Food Nutr Agric; 2022 Nov; 13(1):3-16. PubMed ID: 34053432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System.
    Yamagishi SI; Matsui T; Ishibashi Y; Isami F; Abe Y; Sakaguchi T; Higashimoto Y
    Curr Pharm Des; 2017; 23(8):1135-1141. PubMed ID: 27774900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
    Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
    Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemicals against anti-diabetic complications: targeting the advanced glycation end product signaling pathway.
    Parveen A; Sultana R; Lee SM; Kim TH; Kim SY
    Arch Pharm Res; 2021 Apr; 44(4):378-401. PubMed ID: 33837513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of advanced glycation end products in cellular signaling.
    Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
    Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
    Sourris KC; Watson A; Jandeleit-Dahm K
    Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of advanced glycation endproduct formation by foodstuffs.
    Wu CH; Huang SM; Lin JA; Yen GC
    Food Funct; 2011 May; 2(5):224-34. PubMed ID: 21779560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE/TLR4-reactive oxygen species-activated NF-kβ nexus.
    Jahan H; Choudhary MI
    Eur J Pharmacol; 2021 Mar; 894():173874. PubMed ID: 33460615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders.
    Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2007; 13(27):2832-6. PubMed ID: 17897026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
    Yamagishi SI
    Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting advanced glycation with pharmaceutical agents: where are we now?
    Borg DJ; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
    Bongarzone S; Savickas V; Luzi F; Gee AD
    J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
    Pertynska-Marczewska M; Merhi Z
    Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
    Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
    Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).
    Teodorowicz M; Hendriks WH; Wichers HJ; Savelkoul HFJ
    Front Immunol; 2018; 9():2088. PubMed ID: 30271411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of pheophorbide a as an inhibitor of receptor for advanced glycation end products in Mallotus japonicus.
    Matsumoto T; Matsuno M; Ikui N; Mizushina Y; Omiya Y; Ishibashi R; Ueda T; Mizukami H
    J Nat Med; 2021 Jun; 75(3):675-681. PubMed ID: 33625682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.